首页> 外文期刊>The Journal of Pharmacology and Experimental Therapeutics: Official Publication of the American Society for Pharmacology and Experimental Therapeutics >Cannabinoid CB1 and cholecystokinin CCK2 receptors modulate, in an opposing way, electrically evoked (3H)GABA efflux from rat cerebral cortex cell cultures: possible relevance for cortical GABA transmission and anxiety.
【24h】

Cannabinoid CB1 and cholecystokinin CCK2 receptors modulate, in an opposing way, electrically evoked (3H)GABA efflux from rat cerebral cortex cell cultures: possible relevance for cortical GABA transmission and anxiety.

机译:大麻素CB1和胆囊收缩素CCK2受体以相反的方式调节大鼠大脑皮层细胞培养物中的电诱发(3H)GABA外排:可能与皮质GABA传递和焦虑有关。

获取原文
获取原文并翻译 | 示例
           

摘要

The effects of treatments with cannabinoid (CB)(1) and cholecystokinin (CCK)(2) receptor agonists and antagonists, as well as compounds that enhance endocannabinoid signaling by inhibiting degradation, e.g., the fatty acid amide hydrolase inhibitor 3'-carbamoyl-biphenyl-3-yl-cyclohexylcarbamate (URB597) or the endocannabinoid reuptake inhibitor (5Z,8Z,11Z,14Z)-N-(3-furanylmethyl)-5,8,11,14-eicosatetraenamide (UCM707), were studied both on spontaneous and electrically evoked [(3)H]GABA efflux from rat cerebral cortex cell cultures. The CCK(2) receptor agonist CCK-8S, the CB(1) receptor agonist (R)-(+)-[2,3-dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzox azin-6-yl]-1-naphthalenylmethanone (WIN55,212-2), URB597, UCM707, the CB(1) receptor antagonist N-piperidino-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-3-pyrazole-carbox amide (SR141716A), and the CCK(2) receptor antagonist 2-[2-(5-Br-1H-indol-3-yl)ethyl]-3-[3-(1-methylethoxy)phenyl]-4-(3H)-quinazolinone (LY225910) did not affect spontaneous [(3)H]GABA efflux. CCK-8S concentration-dependently increased electrically evoked [(3)H]GABA overflow, and this effect was prevented by LY225910. WIN55,212-2, URB597, and UCM707 induced a reduction of electrically evoked [(3)H]GABA overflow. This reduction was counteracted by SR141716A. When CCK-8S and one of cannabinoid-interfering compounds were simultaneously added, at concentrations by themselves ineffective, to the superfusion medium, an enhancement in electrically evoked [(3)H]GABA efflux was observed. This increase was counteracted by either SR141716A or LY225910 as well as by the inhibitor of protein kinase C, (1R)-2-[12-[(2R)-2-(benzoyloxy)propyl]-3,10-dihydro-4,9-dihydroxy-2,6,7,11-tetram ethoxy-3,10-dioxo-1-perylenyl]-1-methylethylcarbonic acid 4-hydroxyphenyl ester (calphostin C). These results indicate that CB(1) and CCK(2) receptors modulate, in an opposing way, electrically evoked [(3)H]GABA efflux from rat cerebral cortex cell cultures. The existence of a CB(1)/CCK(2) receptor heteromer on cortical GABA terminals, with a possible relevance for cortical GABA transmission and anxiety, is postulated.
机译:大麻素(CB)(1)和胆囊收缩素(CCK)(2)受体激动剂和拮抗剂以及通过抑制降解增强内源性大麻素信号传导的化合物(例如,脂肪酸酰胺水解酶抑制剂3'-氨基甲酰基-研究了联苯-3-基-环己基氨基甲酸酯(URB597)或内源性大麻素再摄取抑制剂(5Z,8Z,11Z,14Z)-N-(3-呋喃基甲基)-5,8,11,14-二十碳四烯酰胺(UCM707)从大鼠大脑皮层细胞培养物中自发和电诱发的[(3)H] GABA外排。 CCK(2)受体激动剂CCK-8S,CB(1)受体激动剂(R)-(+)-[2,3-dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo [1,2, 3-de] -1,4-benzox azin-6-yl] -1-萘甲酮(WIN55,212-2),URB597,UCM707,CB(1)受体拮抗剂N-哌啶子基-5-(4-氯苯基) -1-(2,4-二氯苯基)-4-甲基-3-吡唑-羧酰胺(SR141716A)和CCK(2)受体拮抗剂2- [2-(5-Br-1H-吲哚-3-yl )乙基] -3- [3-(1-甲基乙氧基)苯基] -4-(3H)-喹唑啉酮(LY225910)不影响自发的[(3)H] GABA流出。 CCK-8S浓度依赖性地引起电诱发的[(3)H] GABA溢出,而LY225910阻止了这种作用。 WIN55,212-2,URB597和UCM707引起电诱发的[(3)H] GABA溢出减少。 SR141716A抵消了这种减少。当将CCK-8S和一种大麻素干扰化合物同时以自身无效的浓度添加到超融合培养基中时,观察到电诱发的[(3)H] GABA外排增强。 SR141716A或LY225910以及蛋白激酶C的抑制剂(1R)-2- [12-[(2R)-2-(苯甲酰氧基)丙基] -3,10-二氢-4, 9-二羟基-2,6,7,11-四乙氧基-3,10-二氧-1-perylenyl] -1-甲基乙基碳酸4-羟基苯酯(钙磷蛋白C)。这些结果表明,CB(1)和CCK(2)受体以相反的方式调节从大鼠大脑皮层细胞培养物中诱发的[[3)H] GABA外排。假设在皮质GABA末端存在CB(1)/ CCK(2)受体异聚体,可能与皮质GABA的传递和焦虑有关。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号